TWIST1 and triple-negative breast carcinoma: Additionally, with regard to molecular subtypes, Twist expression was significantly higher in triple-negative breast cancer (55/63, 87.3%), followed by the HER2-overexpressing subtype (51/71, 71.8%), Luminal B (25/48, 52.1%) and Luminal A types (89/226, 39.4%) (P < 0.001).